Conjoint Analysis of Patient Preferences in Joint Interventions
Launched by DUKE UNIVERSITY · Jan 22, 2016
Trial Information
Current as of November 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is designed to understand what treatment choices people with various joint and bone conditions prefer, by testing a questionnaire and a simple decision tool. Researchers want to learn how factors like pain, recovery time, cost, and the option of surgery versus non-surgical care influence what people choose. The study covers about 12 conditions, including hip and knee arthritis, hip labral problems (FAI), osteochondritis dissecans, several fractures (hip, ankle, tibia, proximal humerus, distal radius), Achilles tendon rupture, and ankle arthritis, among others.
People who might be eligible include adults roughly 18 to 85 years old, depending on the condition, with most conditions allowing adults 18 and up to about 80s or 85. A few conditions also involve children (ages 8-18) with a parent or guardian. All participants must be able to read and understand English to consent. The study is led by Duke University and is enrolling by invitation at Duke University Health System in Durham, North Carolina, with an expected total of about 2,310 participants. Participants will be asked to complete surveys over the coming years, comparing a new decision tool to standard treatment information to see how information and options influence their treatment choices; the goal is to improve how we understand and support patient decision-making, not to test a new medical therapy. Individual data will not be shared publicly. Enrollment is ongoing, with completion anticipated in 2027.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient age criteria for each condition is listed below:
- • 1. Hip arthritis: 50-80 years
- • 2. Knee arthritis: 50-80 years
- • 3. Hip labral tears and FAI: 18-65
- • 4. Osteochondritis dissecans: parents with children between the ages of 8-18
- • 5. Achilles tendon rupture: 25-60 years
- • 6. Patellofemoral dislocation: parents with children between the ages of 8-18 and adults between 18-50 years of age
- • 7. Distal radius fracture: 18-80 years
- • 8. Hip fracture: 50-85 years
- • 9. Ankle fracture: 18-80 years
- • 10. Tibia fracture: 18-80 years
- • 11. Proximal humerus fracture: 18-80 years
- • 12. Ankle Arthritis: 40-80 years
- Exclusion Criteria:
- • Inability to read, understand and give effective English consent
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Richard C. Mather III, MD, MBA
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials